← Leaderboards
Nancy J Halas
Rice University
$2,291,936
Attributed
$2,291,936
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $613.6K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,291,936 · 2
By mechanism
U01$1,678,319 · 1
P42$613,617 · 1
Top collaborators
No co-investigators on record.
Most similar at Rice University
Same institution · by research overlap
- Dmitri Lapotko$2,798,530
- Rebecca Rae Richards-Kortum$39,668,312
- Kytai Truong Nguyen$5,293,396
- Jennifer L West$6,423,429
- Adil Yousif Shamoo$4,871,085
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularOpticsEnvironmentMedicineIn VivoMalignant NeoplasmsImage Guided TherapyDrug KineticsFluorescenceHybridsIntervention StudiesIn VitroIron OxideMalignant Neoplasm Of PancreasCollegeBaseBiodistributionDiagnosisContrast MediaAnimalsGoldGeographic DistributionAnimal ModelMethodology
Grant awards (6)
Project 1: Streamlined identification of PAHs/PACs in environmental samples using ultracompact spectroscopy platforms and machine learning strategies$613,617
P42 · FY2025 · ES · contact PI
Preclinical platform for theranostic nanoparticles in pancreatic cancer$330,019
U01 · FY2014 · CA · contact PI
Preclinical platform for theranostic nanoparticles in pancreatic cancer$267,620
U01 · FY2013 · CA · contact PI
Preclinical platform for theranostic nanoparticles in pancreatic cancer$345,225
U01 · FY2012 · CA · contact PI
Preclinical platform for theranostic nanoparticles in pancreatic cancer$347,838
U01 · FY2011 · CA · contact PI
Preclinical platform for theranostic nanoparticles in pancreatic cancer$387,617
U01 · FY2010 · CA · contact PI